Transcarent, led by Livongo Health founder Glen Tullman, bought public market competitor Accolade in January for $621 million, about half of Accolade's IPO price when the benefits navigator went ...

We built our IPO process in partnership with the investment banking community, ensuring that they have the control and information they need to successfully open your IPO. Nasdaq’s best-in-class ...

Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...

IPOs offer potential for high growth, as demonstrated by the historical success of companies like Amazon. The IPO market is recovering, with new significant entries like Reddit and Serve Robotics ...

Saudi Arabia is experiencing a boom in IPO activity, signaling the liberalization of its economy and a shift away from ...